CNN: Moderna applies for FDA authorization of its COVID-19 vaccine
First patient enrolled in UC/UC Health Moderna vaccine trial tells his story
Jarelle Marshall, the first patient administered a dose in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience. Marshall received the first dose on August 25, 2020 with a follow up dose about four weeks later.
When asked by CNN host Don Lemon about what getting a dose was like, Marshall said, "Other than a sore arm I didn't have any really negative side effects. After the second injection, the day after, my temperature rose a couple degrees around 99 for about a day which made me a little nervous. I was checking my temperature every hour or two. But after that, you know, I was fine. I didn't get sick or didn't have any problems."
Marshall also said that one of the reasons he volunteered for the trial was to set an example for his son.
"I always tell my son, what really matters is what you do when people aren't looking."
Watch the entire segment here and read more about the UC/UC Health Moderna vaccine trial here.
Lead photo Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Residents concerned about high concentration of low-income...
May 16, 2024
Efforts to build more affordable housing in Cincinnati have created concerns for residents as low-income housing has been concentrated in some of the city’s poorest neighborhoods, WCPO reported. Gary Painter, PhD, the academic director of the University of Cincinnati’s Carl H. Lindner College of Business real estate program and a professor of real estate, said a complaint against the city could lead to positive outcomes.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.